Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human placenta-derived cells have mesenchymal stem/progenitor cell potential.

Yumi Fukuchi1, Hideaki Nakajima, Daisuke Sugiyama

  • 1Division of Cellular Therapy, The Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, 108-8639, Japan. yfukuchi@ims.u-tokyo.ac.jp

Stem Cells (Dayton, Ohio)
|September 3, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Local, but not circulating, complement C3 shapes immune checkpoint blockade efficacy by controlling myeloid cell infiltration.

Nature communications·2026
Same author

The role of the pericapsular nerve group block in early mobilisation and functional recovery after total hip arthroplasty: A systematic review and meta-analysis.

Indian journal of anaesthesia·2026
Same author

An Improved Brain-Penetrating Nanoformulation of the VIPR2 Antagonist Peptide KS-133 for Treating Cognitive Impairment in Schizophrenia.

Biological & pharmaceutical bulletin·2026
Same author

Effect of Pericapsular Nerve Group Block on Prehabilitation in Femoral Neck Fractures: A Randomized, Double-Blind, Placebo-Controlled Trial.

Anesthesia and analgesia·2026
Same author

Postoperative delirium in hip fracture patients linked to epigenetic alterations in inflammatory and immune pathways: a genome-wide DNA methylation study.

Translational psychiatry·2026
Same author

On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastoma.

Science translational medicine·2026

Human placenta contains rare cells with Mesenchymal Stem/Progenitor Cell (MSC) potential. These placenta-derived cells exhibit MSC-like characteristics and differentiation capabilities, suggesting a valuable new source for MSC research.

Area of Science:

  • Stem Cell Biology
  • Regenerative Medicine
  • Human Placenta Research

Background:

  • Mesenchymal stem/progenitor cells (MSCs) are found in various adult and fetal tissues but are rare.
  • Identifying alternative, abundant sources of MSCs is crucial for research and therapeutic applications.

Purpose of the Study:

  • To identify and characterize cells with Mesenchymal Stem/Progenitor Cell (MSC)-like potency within the human placenta.
  • To evaluate the potential of placenta-derived cells as a source for MSCs.

Main Methods:

  • Isolation of adherent cells from trypsin-digested term human placentas.
  • Establishment of cell clones using limiting dilution.
  • Analysis of cell morphology, surface markers, gene expression (RT-PCR), and differentiation potential (osteogenesis, adipogenesis) using fluorescence-activated cell sorting (FACS).

Related Experiment Videos

Main Results:

  • Two clones of placenta-derived cells exhibited Mesenchymal Stem/Progenitor Cell (MSC)-like morphology.
  • These cells expressed key stem cell markers, hematopoietic/endothelial cell-related genes, and organ-specific genes.
  • Demonstrated osteogenic and adipogenic differentiation potential under specific culture conditions.

Conclusions:

  • Placenta-derived cells possess multilineage differentiation potential comparable to Mesenchymal Stem/Progenitor Cells (MSCs).
  • The human placenta represents a promising and potentially abundant source of Mesenchymal Stem/Progenitor Cells (MSCs).